Rising number of neurological, and retinal disorders, increasing investment in optogenetics, and growing adoption of optogenetics in the treatment of neurophysiological conditions are the key factor fueling the growth of the global optogenetics actuators and sensors market.
A photo sensitive protein or opsin, and light are the key components of optogenetics. Light of different wavelength or colors can activate neurons with excitatory opsins, inhibit neurons with inhibitory opsins, or initiate cellular signaling cascades. The optogenetic activation is similar to the electrical activation or stimulation used for the treatment of neurological disorders. However, in electrical activation, every fiber in a nerve bundle or cell in the brain region gets stimulated along with the target nerve or cell.
However, optogenetics facilitates precise stimulation of the nerve or cell under consideration and thus exhibits high throughput and improved efficacy. This has resulted in rising adoption of optogenetics therapeutics for the treatment of neurological and retinal disorders. The global optogenetics actuators and sensors market is anticipated to exhibit significant growth during the forecast period.
North America contributed the largest share to the global optogenetics actuators and sensors market in 2019 and is anticipated to be the dominating geography throughout the forecast period. Prevalence and growth of neurological disorders, increasing incidences of glaucoma, and increasing investment in research & development activities are the major factors fueling the demand and growth of optogenetics actuators and sensors market in North America.
Asia Pacific is anticipated to be the most lucrative market segment during the forecast period owing to expanding healthcare infrastructure and growing investment in research & development of healthcare technology.
The report titled “Optogenetics Actuators and Sensors Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032”, wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global optogenetics actuators and sensors market.
Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Danaher Corporation reported revenues of USD 17,911.1 million in 2019 and the product segment analysis of the company indicates that Life Sciences business segment of the company dominated revenue in 2019.
The global optogenetics actuators and sensors market is segmented based on product type, applications, and geography. Based on product type, the global optogenetics actuators and sensors market is segmented into actuators, and sensors. The actuators are further sub-segmented into channelrhodopsin halorhodopsin, and archaerhodopsin. The sensors are further segmented into genetically encoded calcium indicators, voltage-sensitive fluorescent proteins, pH sensors, and others. Based on applications, the global optogenetics actuators and sensors market is segmented into retinal disorders, Parkinson’s disease, anxiety & depression, autism, schizophrenia, and others. Based on geography, the global optogenetics actuators and sensors market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The research would provide in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on optogenetics actuators and sensors. Market share of prominent companies in the global optogenetics actuators and sensors market would be included.
For instance, Danaher Corporation operates through three business segments namely Life Science, Diagnostics, and Environmental & Applied Solutions. The optogenetics actuators and sensors are delivered under Diagnostics business segment of the company with revenue contribution of US$ 6.6 million in 2019.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the optogenetics actuators and sensors companies. Furthermore, the global optogenetics actuators and sensors market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
Product portfolio would focus on all the products under the optogenetics actuators and sensors business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global optogenetics actuators and sensors market.
Major players active in the global optogenetics actuators and sensors market include Addgene, Bruker Corporation, Circuit Therapeutics, Inc., Coherent, Inc., Danaher Corporation, Elliot Scientific Ltd., Gensight Biologics S.A., Judges Scientific Plc, Merck KGaA, Noldus Information Technology, Prizmatix, Shanghai Laser & Optics Century Co., Ltd. (SLOC), The Applied Genetic Technologies Corporation (AGTC), The Jackson Laboratory, and Thorlabs, Inc.
Market Segmentation:
By product type
- actuators
- channelrhodopsin halorhodopsin
- archaerhodopsin
- sensors
- genetically encoded calcium indicators
- voltage-sensitive fluorescent proteins
- pH sensors
- others
By applications
- retinal disorders
- Parkinson’s disease
- anxiety & depression
- autism
- schizophrenia
- others
By Geography
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
